OpenAI Launches Rosalind Biodefense Program — GPT-Rosalind for Government and Trusted Developers

OpenAI Blog·high signal

OpenAI announced Rosalind Biodefense on May 29, expanding access to GPT-Rosalind — a frontier reasoning model for biology, drug discovery, and translational medicine — to vetted developers and U.S. government partners. The program sponsors access for epidemiological modeling, early detection, and pandemic preparedness. OpenAI briefed the White House and federal agencies and is involving public-health-focused agencies.